- CODEN : IAJPBB
- issn 2349-7750
TITLE:
TREATMENT OF BENIGN AND BORDERLINE BONE TUMORS WITH COMBINED CURRETTAGE AND BONE DEFECT RECONSTRUCTION
AUTHORS:
Najeeb ur Rehman, Hussain Bux Palh, Mansoor Ali Abbasi, Aatir H. Rajput, Muhammad Muneeb, Abid Ali
ABSTRACT:
Background: The management of bone defects following simple curettage of bone tumors is controversial, demands dexterity and can be mastered only through experience of oneself and others. In light of numerous emerging substitutes, the use of cancellous allograft bone in the treatment of benign and borderline bone tumors merits documentation. Objective: To review the use of combine curettage and bone defect reconstruction for benign and borderline tumors. Methodology: This observational, retrospective analysis was conducted upon the medical records of 164 consecutive patients with benign or borderline bone tumors treated with simple curettage at the Dept. of Orthopedic Surgery at from January 2014 to December 2018. Postoperative radiological changes were evaluated by a modified Neer’s classification in defects that were subsequently reconstructed with allograft bone (n = 133). Data was recorded onto a pre-structured questionnaire. Data obtained was analyzed using SPSS version 21.0 and MS. Excel 2013. Results: Simple curettage with subsequent defect filling using allograft bone was the surgical procedure performed in the majority of our patients (81%) and was associated with a low overall 2.5-year local recurrence (LR; 9.8%) and complication rate (7.5%). The radiological appearance of the grafted defects was deemed satisfactory in 85% of cases, with signs of either complete or partial healing present 6–12 months postoperatively. With respect to pathology, we found high rates of LR in giant cell tumors (GCTs) of bone, simple cysts (SCs) in children, and preexisting local recurrent disease. We did not observe any allograft-related complications. Conclusion: After careful evaluation of the results, it can be safely concluded that simple curettage and bone defect reconstruction with bone allograft is a sufficient treatment for most benign bone lesions and is associated with a low complication rate. For high- risk entities, such as GCTs of bone, SCs in children, and recurrent disease, additional adjuvant treatment could be considered to avoid LR. Keywords: Benign Bone Tumor, Borderline Bone Tumor, Combine Currettage, Bone Allograft & Local Recurrence
FULL TEXT
Approved Journal
NLM ID:101711216 [Serial]
Included in EuroPub database
ICV 2015 - 61.16
Indexed In
S.J Impact Factor:7.157
cosmos Impact Factor:4.153
ICMJE Recommendations
IP Indexing Impact Factor: 2.76
Cover Page
